BABY Else Nutrition Holdings Inc

Else Nutrition Launches World's First Globally Patented, Plant-Based Toddler Nutrition formula on Amazon.com

Amazon to begin online sales of Else Soy free Plant-Based Toddler Nutrition in the U.S.

VANCOUVER, British Columbia, Canada -- September 24, 2020 -- InvestorsHub NewsWire -- ELSE NUTRITION HOLDINGS INC. (TSX-V: BABY) (OTCQB: 1BABYF) (FSE: 0YL) ("Else" or the "Company"), is pleased to announce that its novel, first of its kind plant-based soy free Complete & clean label Nutrition for Toddlers is now available for U.S customers via Amazon.com.

Else is expanding into the world's largest online retailer as consumers continue to eat more meals at home and increasingly rely on grocery delivery services, during the COVID-19 pandemic. Amazon saw online grocery sales triple year-over-year during the second quarter of 2020, as more customers continue to get their groceries delivered rather than going to a physical store. 

Selling direct to consumers through online channels, is a major pillar of Else's global go-to-market strategy.  Furthermore, the Company's Amazon store will provide a convenient alternative for parents who prefer shopping online.

In addition to its own e-store and the new the Amazon.com store, the Company is aggressively pursuing new channels to bring its novel products to natural food and grocery store aisles and store shelves across the United States.  Grocers are eager to satisfy consumer's growing demand for natural, clean, non-dairy and healthy alternative product offerings in the Company's product category. This is further amplified given the massive growth and demand they are currently experiencing as a result of stay at home orders and restaurant closures.

As a result of both a consumer demand – plant-based products continue to significantly outpace overall food sales in the U.S., fueling a significant growth opportunity for retailers.

"We're thrilled to offer Else Nutrition's products US nation wide on Amazon.com," said Mrs. Hamutal Yitzhak, CEO and Co-Founder of Else. "With the launch of our plant-based Toddler complete nutrition, we've been getting many requests from customers who want to purchase our product on Amazon.com. This is a tremendous convenience and accessibility boost using the world's largest e-commerce platform – as we continue our singular focus to bring novel, plant-based, clean nutrition to families," she added.

Else Nutrition's Plant-Based Complete Nutrition for Toddlers & Babies (12+ mo.) is now available on Amazon.com as both single (for US$36) and 4-pack (for US$136).

Canadian consumers can order Else's products at www.elsenutrition.com.

 To visit Else's Amazon please see: https://www.amazon.com/dp/B08FM4NRMR/ref=cm_sw_r_wa_api_fab_ZBGAFb01N25NV

Else is pleased to announce that as of September 14, 2020, it retained Winning Media LLC ("Winning Media") for digital marketing and advertising services. Winning Media will be engaged on a month to month term and will be compensated a total of USD$75,000 for its current scope of services. Neither Winning Media nor Else currently own securities in each other. The engagement is subject to approval from the TSX Venture Exchange. 

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else's Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board  members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies,  and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

Media Contact:

Covet Consumer Business Unit

Gianna Totaro

elsenutrition@powerdigitalmarketing.com

P: 1-301-875-6574

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: hamutaly@elsenutrition.com
P: +972(0)3-6445095

Mr. Sokhie Puar, Director
ELSE Nutrition Holdings Inc.
E: sokhiep@elsenutrition.com
P: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will", "expect" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company's financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.